Delivery Order SPE2DB22D2007-SPE2DB24FH9VA
- Not listed
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of BRUKINSA 80 MG CAPSULES 120S. The contract has a potential value of $6,765.08 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with the Defense Logistics Agency, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,861 units of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $7,242.15 and an ultimate completion date of July 2, 2024. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which is a major acquisition and logistics agency supporting the U.S. Department of Defense. Amerisourcebergen, a large...
- AmerisourceBergen Drug Corp has been awarded a $6,370 delivery order by the Defense Logistics Agency (DLA) for BRUKINSA 80 mg capsules (120-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 12, 2025. The awardee will perform under this delivery order from its corporate headquarters location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $36,210.75 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,087,149 units of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. This order was placed under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of BRUKINSA 80 MG CAPSULE 120S. The $50,960.00 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through July 23, 2025. The contract is not set-aside and allows for the delivery of a variety of pharmaceutical and medical products to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,242.15 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. This contract has an ultimate completion date of September 27, 2024. Amerisourcebergen, which operates through its Corporate Office division, is a large for-profit organization that provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award is a Delivery Order with a Firm Fixed Price of $21,726.45 and a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed-price delivery order is for the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This is a $7,242.15 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through August 2024. The contract is a firm-fixed-price type with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. government, including military treatment facilities and...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9VADelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency to provide BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a potential value of $13,530.16. The award has a completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 2/21/24 |